InvestorsHub Logo

Black8

03/12/13 10:53 AM

#35649 RE: cable #35645

Yeah, the restructuring which made it possible for investors to trade EPGL again, the share price gains, the doctors, the scientists, the engineers, the patients that have been helped... It's all just hype. It's all in our imaginations isn't it?

My advice is people better embrace the REALITY and get into EPGL (again) before it is really hard to afford any meaningful number of shares.

EPGL STRONG BUY

mfefree

03/12/13 11:01 AM

#35652 RE: cable #35645

You forgot to lol. If this is a shell, which it's not, what you say would be true. That is not true of epgl and here is why. 1. Shell companies do not have FDA approved devices. 2. Shell companies do not manufacture devices and release them for peer trial. 3. Shell companies do not have their debt replaced by PWc entirely with stock equity. I do not expect revenue numbers this month, buy by June we should be getting some solid numbers. Also, patent applications and products in the pipeline are essential fundementals for a medical device co. Those are the things that will keep restricted shares from being dumped whenever they become unrestricted, because the patents and pipeline increase the value and potential of the company.